Pulmonary Hypertension Patients Find Life With Condition Harder Than Illness Itself

Living with pulmonary arterial hypertension (PAH) presents a unique set of struggles that often overshadow the physical symptoms of the disease itself. Patients describe the daily reality of their condition as "harder than being sick," facing significant hurdles in accessing necessary treatments and gaining societal recognition for their challenges.

One of the most critical barriers is the availability and affordability of medication. "The most important thing is the medicine. You have to take medicine for treatment and maintenance. And you need health insurance for accessibility. If it's not covered by insurance, access is impossible," stated Yoon Young-jin, representative of the Korean Pulmonary Hypertension Patient Association, at a policy forum in August 2025. This lack of insurance coverage makes essential drugs inaccessible for many.

Furthermore, patients often struggle to be recognized as disabled, despite the life-threatening nature of PAH. The condition, characterized by high pressure in the pulmonary arteries, can lead to sudden death but often shows no outward signs. This invisibility leads to misunderstandings and difficulties in accessing support, such as disabled parking spaces, which are crucial for individuals who experience severe breathlessness with minimal exertion.

“

The most important thing is the medicine. You have to take medicine for treatment and maintenance. And you need health insurance for accessibility. If it's not covered by insurance, access is impossible.

The article also points to a frustratingly slow drug approval and negotiation process in South Korea. A new therapy that shows promise in not just slowing but potentially reversing the disease's progression is caught in a pilot program, causing significant delays. This "permit-evaluation-negotiation" process, intended to expedite access, has taken over a year and a half for some patients, leaving them in limbo and making promises of rapid treatment feel hollow.

With an estimated 5,000 PAH patients in South Korea, many of whom are women, the patient association, known as "Bluebirds" for the hope they offer each other, has been advocating for change for two decades. They strive to ensure that patients can live lives as normal as possible, a goal hampered by systemic issues in treatment accessibility. The hope is that upcoming reforms will finally bring South Korea closer to the treatment standards seen in other developed nations.

“

Living as a pulmonary arterial hypertension patient is sometimes harder than being sick.